You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CLINICAL TRIALS PROFILE FOR COVERA-HS


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for COVERA-HS

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00668967 ↗ Bioequivalence Study Of Verapamil Completed Pfizer Phase 1 2008-02-01 The purpose of this study is to demonstrate bioequivalence of single doses of two verapamil formulations
NCT01607073 ↗ Verapamil as Therapy for Children and Young Adults With Dravet Syndrome Completed Ann & Robert H Lurie Children's Hospital of Chicago Phase 2 2012-04-01 This study will assess how well the drug verapamil can improve control of seizures and dysautonomia symptoms in children and young adults diagnosed with Dravet syndrome. The safety of verapamil when given with all concomitant medications will also be assessed.
NCT01607073 ↗ Verapamil as Therapy for Children and Young Adults With Dravet Syndrome Completed Dartmouth-Hitchcock Medical Center Phase 2 2012-04-01 This study will assess how well the drug verapamil can improve control of seizures and dysautonomia symptoms in children and young adults diagnosed with Dravet syndrome. The safety of verapamil when given with all concomitant medications will also be assessed.
NCT01607073 ↗ Verapamil as Therapy for Children and Young Adults With Dravet Syndrome Completed Mayo Clinic Phase 2 2012-04-01 This study will assess how well the drug verapamil can improve control of seizures and dysautonomia symptoms in children and young adults diagnosed with Dravet syndrome. The safety of verapamil when given with all concomitant medications will also be assessed.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for COVERA-HS

Condition Name

Condition Name for COVERA-HS
Intervention Trials
Endoscopic Sinus Surgery 1
FESS 1
Healthy Volunteers 1
Heart Rate 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for COVERA-HS
Intervention Trials
Blood Loss, Surgical 1
Hemorrhage 1
Syndrome 1
Epilepsies, Myoclonic 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for COVERA-HS

Trials by Country

Trials by Country for COVERA-HS
Location Trials
United States 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for COVERA-HS
Location Trials
New Hampshire 1
Minnesota 1
Illinois 1
Connecticut 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for COVERA-HS

Clinical Trial Phase

Clinical Trial Phase for COVERA-HS
Clinical Trial Phase Trials
Phase 2 1
Phase 1 1
Early Phase 1 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for COVERA-HS
Clinical Trial Phase Trials
Completed 2
Not yet recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for COVERA-HS

Sponsor Name

Sponsor Name for COVERA-HS
Sponsor Trials
Assiut University 2
Pfizer 1
Ann & Robert H Lurie Children's Hospital of Chicago 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for COVERA-HS
Sponsor Trials
Other 7
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.